Search

everythinglearnresearchcommunity

for

Search:↓

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Common cosmetic dermatology techniques improve skin damaged by the sun and aging.

Birth control pills can cause skin issues but may help with acne and hirsutism, and choosing the right type can minimize side effects.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Older mice healed wounds better but lost more weight and might have weaker immune systems afterward.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.